Clinical Trial Update: Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating an alternative injection paradigm for onabotulinumtoxinA (BOTOX) in overactive bladder with urinary incontinence has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Urinary Bladder, Overactive, Urinary Incontinence | Phase 4 | Status: COMPLETED | Results posted: 2019-12-24